Ornelas; Martha Alicia
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ornelas; Martha Alicia.The latest application filed is for "crystalline form of a cdk inhibitor".
- Ornelas; Martha Alicia - San Diego CA
| Patent | Date |
|---|---|
| CDK2/4/6 inhibitors Grant 11,396,512 - Behenna , et al. July 26, 2 | 2022-07-26 |
| Crystalline Form Of A Cdk Inhibitor App 20220127262 - Behenna; Douglas Carl ; et al. | 2022-04-28 |
| CDK2/4/6 Inhibitors App 20200392142 - Behenna; Douglas Carl ; et al. | 2020-12-17 |
| CDK2/4/6 inhibitors Grant 10,800,783 - Behenna , et al. October 13, 2 | 2020-10-13 |
| CDK2/4/6 Inhibitors App 20190135817 - Behenna; Douglas Carl ; et al. | 2019-05-09 |
| CDK2/4/6 Inhibitors App 20180044344 - Behenna; Douglas Carl ; et al. | 2018-02-15 |
| Heterocycles Useful As Inhibitors Of Carbonic Anhydrase App 20100256357 - Chong; Wesley Kwan Mung ; et al. | 2010-10-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 